We view shares of the wide-moat firm as a touch undervalued today.
We think investors should keep an eye on P&G as the firm closes its book on its brand rationalization and looks to drive sustainable and profitable growth.
Reckitt Benckiser's fast-growing, highly profitable food-brand mix may offset the deal's rich price tag.
With management already becoming more efficient, the activist investor is unlikely to have a major impact.
We think investors who are interested in this space should keep an eye on the firm, as shares are a bit undervalued.
The move to a warehouse system from direct-store delivery is prudent, but the stock price isn’t compelling.
The wide-moat firm's stable of strong brands, entrenched relationships with retailers, and expansive global scale should ensure it withstands looming headwinds.
By acquiring Pacific Foods, the wide-moat firm is continuing its push into health and wellness.
Although growth has been hard to come by, we think worries related to heightened competitive intensity are creating pockets of value.
A pullback in brand spending has artificially inflated profit levels across the industry, which are unsustainable.
The deal is likely the best outcome for Whole Foods shareholders, while Amazon stands to gain opportunities to drive its grocery business.
We see the strategic benefits of the Whole Foods merger, but given the small relative size of the deal we expect little change to our Amazon fair value estimate.
From our vantage point, the narrow-moat company's tepid sales performance is being hampered by the decision to ratchet back brand marketing.
The firm's leading brand mix, entrenched relationships with retailers, and cost advantages will help Colgate weather its current headwinds.
Brand investments will keep the global snack leader’s competitive advantages intact.
While the narrow-moat firm abandoned its bid for wide-moat Unilever, we doubt its interest in consolidating the space has subsided.
There is some strategic rationale to the tie-up, but given the higher price that would be needed to bring Unilever to the table, we don’t see the takeover as imminent.
Given all of the transformative actions the wide-moat firm is presently undertaking, we don't anticipate investor Nelson Peltz will call for additional steps to transform the business at this time.
Though we'll likely raise our fair value estimate by a dollar or two on the narrow-moat firm, we don't view the risk/reward opportunity as attractive.
Clorox bucked the headwinds of intense competition and slowing global growth with its quarterly results.
The firm’s expansive global scale and brand intangible assets support a wide moat.
We suggest investors interested in the space keep an eye on this wide-moat name.
We'd suggest investors remain on the sidelines of this no-moat retailer as we expect to shave around $1 from our $72 fair value estimate.
Despite tepid near-term growth prospects amid an intensely competitive landscape, pockets of value remain.
While breaking up has proved valuable for peers, we think lagging pricing power and profits will dim ConAgra’s prospects.
We suggest investors interested in the household and personal-care space consider taking a stake in this wide-moat name.
With shares trading at around a 10% discount to our valuation, investors should keep Wal-Mart on their radar screens.
The narrow-moat retailer continues to benefit from its decision to part ways with its lossmaking pharmacy business and efforts to drive organization-wide efficiencies.
Long-term investors should hold off on this narrow-moat name for now.
The narrow-moat firm looks a bit overvalued after mixed third-quarter results.
Shares of this wide-moat firm trade modestly below our valuation and look relatively attractive in an industry where discounts are few and far between.
Leading brands and solid retail relationships give this wide-moat company a competitive advantage, but investors should await a more attractive entry point.
Commodity cost inflation, the need for brand reinvestment, and a shifting business mix mute the wide-moat firm's margin potential.
Cost-saving goals look reasonable, but we think the stock’s overvalued.
Even without a union, these undervalued wide-moat names are attractive for their leading brands and entrenched relationships.
In the face of headwinds, the narrow-moat beauty products company enjoyed a decent quarter, but shares aren't yet attractive.
The retailer looks fairly valued as it posts its eighth consecutive quarter of same-store sales growth.
Despite its well-known brand, convenient locations, and considerable scale, the no-moat retailer is unattractive at its current price.
We'll likely increase our fair value estimate of the narrow-moat food distributor by a few dollars, but we think investors should remain on the sidelines for now.
Input costs, brand spending, and a shifting portfolio mix will impede margin expansion.
As the consumer giant make steady progress, we see the firm's shares as looking modestly undervalued in a pricey sector.
A potential tie-up could be advantageous for both firms, but the Hershey Trust will still be a hurdle to the deal.
But the deal is far from a slam dunk, says Morningstar's Erin Lash.
Input inflation, brand reinvestment needs, and a business mix shift all contribute to our more muted outlook for the company, says Morningstar's Erin Lash.
Long-term investors should warm up to shares trading at a discount to our fair value estimate.
Focusing on its core business has slowed short-term growth for this wide-moat giant, but it sets the stage for profitable growth in the future, writes Morningstar’s Erin Lash.
At home and abroad, consumer defensive firms look to offset muted growth prospects by boosting their brand intangible assets and cost edge.
Recent challenges are unlikely to eat away at Hershey's wide moat.
Despite the recent runup, shares of this critical retailing partner still look attractive.